Author

Chi Kuen Lau

Observed names: C K Lau, Chi K. Lau, Lau, Chi Kuen

Institution: Tseung Kwan O Hospital

Observed institutions: Tuen Mun Hospital, Tseung Kwan O Hospital

OpenAlex ID: A5002032891

Next-generation sequencing with a myeloid gene panel in core-binding factor AML showed KIT activation loop and TET2 mutations predictive of outcome

2016 · C Y Cher, G M K Leung, et al. · Blood Cancer Journal · 43

Distinct mutation spectrum, clinical outcome and therapeutic responses of typical complex/monosomy karyotype acute myeloid leukemia carrying TP53 mutations

2019 · Garret M. K. Leung, Chunxiao Zhang, et al. · American Journal of Hematology · 36

Redefining prognostication of de novo cytogenetically normal acute myeloid leukemia in young adults

2020 · Sze P. Tsui, Ho W. Ip, et al. · Blood Cancer Journal · 13

The impact of bortezomib-based induction in newly diagnosed multiple myeloma with chromosome 1q21 gain

2022 · Hoi Ki Karen Tang, Chi Yeung Fung, et al. · Therapeutic Advances in Hematology · 10

Genetic association between germline JAK2polymorphisms and myeloproliferative neoplasms in Hong Kong Chinese population: a case–control study

2014 · Su Pin Koh, Shea Ping Yip, et al. · BMC Genetics · 9

Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MM

2024 · Hoi Ki Karen Tang, Chi Yeung Fung, et al. · Bone Marrow Transplantation · 5

Management of chronic-phase CML in later lines: a Hong Kong consensus recommendation

2025 · Carol Yuk Man Cheung, Chung Yin Ha, et al. · Annals of Hematology · 1

Real-world outcomes of eltrombopag-containing regimens as frontline treatment for aplastic anemia: A multi-center retrospective study

2025 · Stephen Sze Yuen Lam, Yu Yan Hwang, et al. · Blood

P-181: Treatment outcome and prognostic factors of newly diagnosed Multiple Myeloma receiving Bortezomib-based induction in Hong Kong: an analysis of 448 patients

2021 · Hoi Ki Karen Tang, Chi Yeung Fung, et al. · Clinical Lymphoma Myeloma & Leukemia

P-062: The impact of Bortezomib-based induction on chromosome 1q21 gained newly diagnosed Multiple Myeloma of Chinese origin

2021 · Hoi Ki Karen Tang, Chi Yeung Fung, et al. · Clinical Lymphoma Myeloma & Leukemia

P-048: Clinical application of the weighted cytogenetic scoring system in Multiple Myeloma

2021 · Yu Yan Hwang, Chi Yeung Fung, et al. · Clinical Lymphoma Myeloma & Leukemia

A Mutation Pentad Defined Outcome of De Novo and Cytogenetically Normal Acute Myeloid Leukaemia in Young Adults

2019 · Sze Pui Tsui, Ip HW Alvin, et al. · Blood

Characterization of Genomic Landscape and Risk Stratification of De Novo Cytogenetically Normal Acute Myeloid Leukaemia

2018 · Sze Pui Tsui, Tommy W.F. Tang, et al. · Blood

Clinicopathologic Features, Mutation Spectrum and Clinical Outcome of Complex/Monosomy Karyotype AML in Young Adult Patients in Hong Kong

2017 · Garret Mk Leung, Chunxiao Zhang, et al. · Blood

Clinicopathologic Features and Outcome of Chinese Patients with Myelofibrosis

2014 · Harinder Gill, Yu Yan Hwang, et al. · Blood

A Population Based Study of 408 Cases of Acute Promyelocytic Leukemia Showing Changes in Epidemiology and Prognosis During Two Decades: Impact of Oral Arsenic Trioxide,

2011 · Wing-Yan Au, Dennis Ip, et al. · Blood

Works count: 18

Citation count: 117

H-index: 5

I10-index: 4